Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid

J Wild1, B Grüner, K Metzger

  • 1Institute of Medical Microbiology and Immunology, University of Ulm, Germany.

Vaccine
|June 2, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report.

Infection·2024
Same author

COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.

Annals of hematology·2020
Same author

A soft matter computer for soft robots.

Science robotics·2020
Same author

Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.

The Journal of hospital infection·2018
Same author

Representative Factor Generation for the Interactive Visual Analysis of High-Dimensional Data.

IEEE transactions on visualization and computer graphics·2015
Same author

[Radiological support for the cancer clinic in Dar es Salaam, Tanzania: 30 years of Tanzania tumor aid Heidelberg].

Der Radiologe·2015

This study developed a novel dicistronic DNA vaccine expressing hepatitis B virus (HBV) core (HBcAg) and surface (HBsAg) antigens. This polyvalent vaccine effectively induced both humoral and cellular immune responses in mice.

Area of Science:

  • Immunology
  • Molecular Biology
  • Vaccinology

Background:

  • Hepatitis B virus (HBV) infection is a major global health concern.
  • Current vaccines primarily target the HBV surface antigen (HBsAg).
  • Including the HBV core antigen (HBcAg) may enhance vaccine efficacy.

Purpose of the Study:

  • To develop a novel polyvalent vaccine strategy for Hepatitis B.
  • To assess the coexpression of HBcAg and HBsAg using a dicistronic vector.
  • To evaluate the immunogenicity of a dicistronic DNA vaccine in mice.

Main Methods:

  • Cloning of HBV S and C antigen genes into monocistronic vectors.
  • Construction of a dicistronic expression vector (pCMV/C-S) for coexpression.
  • In vitro transfection studies and in vivo vaccination of mice with plasmid DNA.

Related Experiment Videos

Main Results:

  • Successful coexpression of HBcAg and HBsAg from the dicistronic construct.
  • Induction of humoral immune responses (antibody production) against both HBsAg and HBcAg.
  • Induction of cellular immune responses, including cytotoxic T lymphocyte activity, against both antigens.
  • Effective immune responses observed in mice with different H-2 haplotypes.

Conclusions:

  • Dicistronic expression plasmids offer a novel approach for constructing polyvalent vaccines.
  • A polyvalent vaccine coexpressing HBsAg and HBcAg can elicit robust immune responses.
  • This strategy holds promise for developing more effective Hepatitis B vaccines.